Cargando…

The mutational and phenotypic spectrum of TUBA1A-associated tubulinopathy

BACKGROUND: The TUBA1A-associated tubulinopathy is clinically heterogeneous with brain malformations, microcephaly, developmental delay and epilepsy being the main clinical features. It is an autosomal dominant disorder mostly caused by de novo variants in TUBA1A. RESULTS: In three individuals with...

Descripción completa

Detalles Bibliográficos
Autores principales: Hebebrand, Moritz, Hüffmeier, Ulrike, Trollmann, Regina, Hehr, Ute, Uebe, Steffen, Ekici, Arif B., Kraus, Cornelia, Krumbiegel, Mandy, Reis, André, Thiel, Christian T., Popp, Bernt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371496/
https://www.ncbi.nlm.nih.gov/pubmed/30744660
http://dx.doi.org/10.1186/s13023-019-1020-x
_version_ 1783394561238761472
author Hebebrand, Moritz
Hüffmeier, Ulrike
Trollmann, Regina
Hehr, Ute
Uebe, Steffen
Ekici, Arif B.
Kraus, Cornelia
Krumbiegel, Mandy
Reis, André
Thiel, Christian T.
Popp, Bernt
author_facet Hebebrand, Moritz
Hüffmeier, Ulrike
Trollmann, Regina
Hehr, Ute
Uebe, Steffen
Ekici, Arif B.
Kraus, Cornelia
Krumbiegel, Mandy
Reis, André
Thiel, Christian T.
Popp, Bernt
author_sort Hebebrand, Moritz
collection PubMed
description BACKGROUND: The TUBA1A-associated tubulinopathy is clinically heterogeneous with brain malformations, microcephaly, developmental delay and epilepsy being the main clinical features. It is an autosomal dominant disorder mostly caused by de novo variants in TUBA1A. RESULTS: In three individuals with developmental delay we identified heterozygous de novo missense variants in TUBA1A using exome sequencing. While the c.1307G > A, p.(Gly436Asp) variant was novel, the two variants c.518C > T, p.(Pro173Leu) and c.641G > A, p.(Arg214His) were previously described. We compared the variable phenotype observed in these individuals with a carefully conducted review of the current literature and identified 166 individuals, 146 born and 20 fetuses with a TUBA1A variant. In 107 cases with available clinical information we standardized the reported phenotypes according to the Human Phenotype Ontology. The most commonly reported features were developmental delay (98%), anomalies of the corpus callosum (96%), microcephaly (76%) and lissencephaly (agyria-pachygyria) (70%), although reporting was incomplete in the different studies. We identified a total of 121 specific variants, including 15 recurrent ones. Missense variants cluster in the C-terminal region around the most commonly affected amino acid position Arg402 (13.3%). In a three-dimensional protein model, 38.6% of all disease-causing variants including those in the C-terminal region are predicted to affect the binding of microtubule-associated proteins or motor proteins. Genotype-phenotype analysis for recurrent variants showed an overrepresentation of certain clinical features. However, individuals with these variants are often reported in the same publication. CONCLUSIONS: With 166 individuals, we present the most comprehensive phenotypic and genotypic standardized synopsis for clinical interpretation of TUBA1A variants. Despite this considerable number, a detailed genotype-phenotype characterization is limited by large inter-study variability in reporting. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13023-019-1020-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6371496
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63714962019-02-21 The mutational and phenotypic spectrum of TUBA1A-associated tubulinopathy Hebebrand, Moritz Hüffmeier, Ulrike Trollmann, Regina Hehr, Ute Uebe, Steffen Ekici, Arif B. Kraus, Cornelia Krumbiegel, Mandy Reis, André Thiel, Christian T. Popp, Bernt Orphanet J Rare Dis Research BACKGROUND: The TUBA1A-associated tubulinopathy is clinically heterogeneous with brain malformations, microcephaly, developmental delay and epilepsy being the main clinical features. It is an autosomal dominant disorder mostly caused by de novo variants in TUBA1A. RESULTS: In three individuals with developmental delay we identified heterozygous de novo missense variants in TUBA1A using exome sequencing. While the c.1307G > A, p.(Gly436Asp) variant was novel, the two variants c.518C > T, p.(Pro173Leu) and c.641G > A, p.(Arg214His) were previously described. We compared the variable phenotype observed in these individuals with a carefully conducted review of the current literature and identified 166 individuals, 146 born and 20 fetuses with a TUBA1A variant. In 107 cases with available clinical information we standardized the reported phenotypes according to the Human Phenotype Ontology. The most commonly reported features were developmental delay (98%), anomalies of the corpus callosum (96%), microcephaly (76%) and lissencephaly (agyria-pachygyria) (70%), although reporting was incomplete in the different studies. We identified a total of 121 specific variants, including 15 recurrent ones. Missense variants cluster in the C-terminal region around the most commonly affected amino acid position Arg402 (13.3%). In a three-dimensional protein model, 38.6% of all disease-causing variants including those in the C-terminal region are predicted to affect the binding of microtubule-associated proteins or motor proteins. Genotype-phenotype analysis for recurrent variants showed an overrepresentation of certain clinical features. However, individuals with these variants are often reported in the same publication. CONCLUSIONS: With 166 individuals, we present the most comprehensive phenotypic and genotypic standardized synopsis for clinical interpretation of TUBA1A variants. Despite this considerable number, a detailed genotype-phenotype characterization is limited by large inter-study variability in reporting. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13023-019-1020-x) contains supplementary material, which is available to authorized users. BioMed Central 2019-02-11 /pmc/articles/PMC6371496/ /pubmed/30744660 http://dx.doi.org/10.1186/s13023-019-1020-x Text en © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Hebebrand, Moritz
Hüffmeier, Ulrike
Trollmann, Regina
Hehr, Ute
Uebe, Steffen
Ekici, Arif B.
Kraus, Cornelia
Krumbiegel, Mandy
Reis, André
Thiel, Christian T.
Popp, Bernt
The mutational and phenotypic spectrum of TUBA1A-associated tubulinopathy
title The mutational and phenotypic spectrum of TUBA1A-associated tubulinopathy
title_full The mutational and phenotypic spectrum of TUBA1A-associated tubulinopathy
title_fullStr The mutational and phenotypic spectrum of TUBA1A-associated tubulinopathy
title_full_unstemmed The mutational and phenotypic spectrum of TUBA1A-associated tubulinopathy
title_short The mutational and phenotypic spectrum of TUBA1A-associated tubulinopathy
title_sort mutational and phenotypic spectrum of tuba1a-associated tubulinopathy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371496/
https://www.ncbi.nlm.nih.gov/pubmed/30744660
http://dx.doi.org/10.1186/s13023-019-1020-x
work_keys_str_mv AT hebebrandmoritz themutationalandphenotypicspectrumoftuba1aassociatedtubulinopathy
AT huffmeierulrike themutationalandphenotypicspectrumoftuba1aassociatedtubulinopathy
AT trollmannregina themutationalandphenotypicspectrumoftuba1aassociatedtubulinopathy
AT hehrute themutationalandphenotypicspectrumoftuba1aassociatedtubulinopathy
AT uebesteffen themutationalandphenotypicspectrumoftuba1aassociatedtubulinopathy
AT ekiciarifb themutationalandphenotypicspectrumoftuba1aassociatedtubulinopathy
AT krauscornelia themutationalandphenotypicspectrumoftuba1aassociatedtubulinopathy
AT krumbiegelmandy themutationalandphenotypicspectrumoftuba1aassociatedtubulinopathy
AT reisandre themutationalandphenotypicspectrumoftuba1aassociatedtubulinopathy
AT thielchristiant themutationalandphenotypicspectrumoftuba1aassociatedtubulinopathy
AT poppbernt themutationalandphenotypicspectrumoftuba1aassociatedtubulinopathy
AT hebebrandmoritz mutationalandphenotypicspectrumoftuba1aassociatedtubulinopathy
AT huffmeierulrike mutationalandphenotypicspectrumoftuba1aassociatedtubulinopathy
AT trollmannregina mutationalandphenotypicspectrumoftuba1aassociatedtubulinopathy
AT hehrute mutationalandphenotypicspectrumoftuba1aassociatedtubulinopathy
AT uebesteffen mutationalandphenotypicspectrumoftuba1aassociatedtubulinopathy
AT ekiciarifb mutationalandphenotypicspectrumoftuba1aassociatedtubulinopathy
AT krauscornelia mutationalandphenotypicspectrumoftuba1aassociatedtubulinopathy
AT krumbiegelmandy mutationalandphenotypicspectrumoftuba1aassociatedtubulinopathy
AT reisandre mutationalandphenotypicspectrumoftuba1aassociatedtubulinopathy
AT thielchristiant mutationalandphenotypicspectrumoftuba1aassociatedtubulinopathy
AT poppbernt mutationalandphenotypicspectrumoftuba1aassociatedtubulinopathy